MedPath

Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)

Completed
Conditions
Alzheimer Disease
Interventions
Drug: alphatocopherol
Drug: Placebo replacement for Selenium
Drug: Placebo replacement for vitamin E
Registration Number
NCT00040378
Lead Sponsor
Frederick Schmitt
Brief Summary

The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a prevention trial, PREADVISE is trying to find out if taking selenium and/or Vitamin E supplements can help to prevent memory loss and dementia such as Alzheimer's disease.

Detailed Description

Studies show that increased oxidative stress (from excess free radicals) may damage brain cells and is linked with Alzheimer's disease (AD). Many studies show increased oxidation of brain lipids (fats), proteins, carbohydrates (sugars) and DNA in AD. Although the causes of AD are not known, it is believed that oxidative stress is part of what damages brain cells in AD and probably other brain diseases. Animal and tissue culture studies of vitamin E and selenium suggest that they can protect brain cells from damage. This research study is being done to see how safe and effective vitamin E and selenium may be in preventing AD and other brain illnesses. These illnesses are more common in people over the age of 60 to 65. A potential benefit of participating in the PREADVISE study is that early detection of memory changes can lead to early diagnosis and treatment. Also, some participants may decrease their risk of getting AD if the supplements are effective. The findings of this study may also help in the research and understanding of AD.

Only participants who are taking part in the SELECT study (a study that looks at the use of vitamin E and selenium for preventing prostate cancer) may apply to participate in the PREADVISE study about how useful vitamin E and selenium might be for preventing memory changes with age (including Alzheimer's disease and other disease that can affect the brain). African American and Hispanic men who are age 60 or older may take part. Men of other ethnic groups aged 62 or older may take part. The SELECT doctors or staff will review the applicant's medical history and drugs to verify that they have no conditions that would exclude them from this study. About 10,000 men will take part in this study.

The PREADVISE study examinations will be done during the participant's annual SELECT visit at the clinic where the SELECT studies are being conducted. There will be one study visit for each year the participants are in SELECT (7 to 12 visits). Each visit for PREADVISE will consist of a brief screening of the participant's memory, and an update (if any) of the participant's family history of dementia and medications. If memory changes are suggested by the brief memory screen, the participant will be asked to take a longer memory screen to further evaluate the potential for memory changes. If the longer memory screen also suggests problems with the participant's memory, the participant will be asked to see his family doctor or a PREADVISE doctor for a more complete medical exam to find the possible causes of the memory change. Results of the doctor's medical exam, with the consent of the participant, will be sent to the PREADVISE doctors for their review to help with the diagnosis. Results of the memory checks will not be given to the participants. However, if the participant does have a medical workup for memory changes, this information will be given to the family doctor after the medical workup is completed. A portion of the blood sample that was taken when the participant entered SELECT might be analyzed and tested for a genetic risk factor associated with Alzheimer's disease, called Apolipoprotein E (ApoE). The results of this test will be used for research purposes only.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
4246
Inclusion Criteria
  • Participating in SELECT Prevention study;
  • 62 years or older if other ethnic origin, or 60 years or older if African-American or Hispanic;
  • General good health with no neurological or psychiatric illness.
Exclusion Criteria

The SELECT doctors or staff will review the PREADVISE applicants' medical history and drugs to verify that they have no condition(s) that would exclude them from this study. The participant must not have any of the following neurological conditions based on self report (were told by a physician):

  • Alzheimer's disease, or any other form of dementia such as Pick's disease, dementia with Lewy bodies, frontotemporal dementia, vascular dementia, significant cognitive and motor impairment from a stroke or corticobasal degeneration;
  • Huntington's disease, epilepsy, Parkinson's disease, brain tumor, multiple sclerosis, manic-depressive disorder, or schizophrenia;
  • The participant must not have had a head injury with prolonged loss of consciousness (over 30 minutes) within the past five years;
  • The participant must not have a current alcohol or substance abuse diagnosis, or must have been treatment free for the past 24 months;
  • The participant must not have had a diagnosis of depression or anxiety disorder in the past 4 months and must not currently be under treatment for depression or anxiety disorder. [A participant who was previously diagnosed with depression or anxiety disorder but completed treatment more than four months ago is eligible.];
  • The participant must not currently use of any of the following medications: Aricept, Cognex, Exelon, Reminyl, or Hydergine;
  • The participant must not have blindness, deafness, language difficulties or any other disability that may prevent completion of the memory screen.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Combination therapyalphatocopherolvitamin E (alphatocopherol) and selenium
Vitamin E onlyalphatocopherolvitamine E (alphatocopherol) and placebo
Vitamin E onlyPlacebo replacement for Seleniumvitamine E (alphatocopherol) and placebo
Selenium onlyPlacebo replacement for vitamin Eselenium and placebo (Placebo replacement for vitamin E)
PlaceboPlacebo replacement for vitamin Eplacebo (Placebo replacement for vitamin E) and placebo (Placebo replacement for selenium)
PlaceboPlacebo replacement for Seleniumplacebo (Placebo replacement for vitamin E) and placebo (Placebo replacement for selenium)
Combination therapySeleniumvitamin E (alphatocopherol) and selenium
Selenium onlySeleniumselenium and placebo (Placebo replacement for vitamin E)
Primary Outcome Measures
NameTimeMethod
incidence of dementia (including Alzheimer's disease)7 to 12 years (depending on enrollment date)

Participants will complete a modified Telephone Interview of Cognitive Status (TIC-S) to evaluate the onset of dementia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (91)

Duluth CCOP

🇺🇸

Duluth, Minnesota, United States

NW Ohio Oncology Center/St. Luke's Hospital

🇺🇸

Maumee, Ohio, United States

Marshfield Clinic

🇺🇸

Marshfield, Wisconsin, United States

Virginia Mason CCOP

🇺🇸

Seattle, Washington, United States

Northwest Hospital

🇺🇸

Seattle, Washington, United States

Good Samaritan Hospital

🇺🇸

Cincinnati, Ohio, United States

Stormont-Vail Health Care/Cotton O'Neil Clinic

🇺🇸

Topeka, Kansas, United States

Wichita CCOP

🇺🇸

Wichita, Kansas, United States

Columbus CCOP

🇺🇸

Columbus, Ohio, United States

VAMC San Juan

🇵🇷

San Juan, Puerto Rico

San Juan City Hospital - PR, Hematology Oncology Office

🇵🇷

San Juan, Puerto Rico

University of Alabama at Birmingham Preventive Medicine

🇺🇸

Birmingham, Alabama, United States

Glendale Memorial Hospital

🇺🇸

Glendale, California, United States

University of California, San Diego

🇺🇸

La Jolla, California, United States

University of California, San Diego - Chula Vista

🇺🇸

Chula Vista, California, United States

Alaska Regional Hospital

🇺🇸

Anchorage, Alaska, United States

Providence Alaska Medical Center

🇺🇸

Anchorage, Alaska, United States

VA Medical Center

🇺🇸

Loma Linda, California, United States

Northridge Hospital Medical Center

🇺🇸

Northridge, California, United States

VAMC Long Beach

🇺🇸

Long Beach, California, United States

Santa Rosa Memorial Hospital Regional CCOP

🇺🇸

Santa Rosa, California, United States

Lionel B. Katchem

🇺🇸

Upland, California, United States

LABIOMED (Los Angeles Biomedical) Research Institute at Harbor-UCLA Medical Center

🇺🇸

Torrance, California, United States

Rocky Mountain CC/Poudre Valley Hospital

🇺🇸

Fort Collins, Colorado, United States

George Washington University Medical Center

🇺🇸

Washington, District of Columbia, United States

DC United MBCCOP

🇺🇸

Washington, District of Columbia, United States

Sibley Memorial Hospital

🇺🇸

Washington, District of Columbia, United States

Baptist Medical Center

🇺🇸

Jacksonville, Florida, United States

Bliss Cancer Center/McFarland Clinic/Mary Greely MC

🇺🇸

Ames, Iowa, United States

Kaiser Southeast Permanente Medical Group

🇺🇸

Tucker, Georgia, United States

Cedar Rapids CCOP

🇺🇸

Cedar Rapids, Iowa, United States

Genesis Medical Center

🇺🇸

Davenport, Iowa, United States

Our Lady of Bellefonte Hospital Inc.

🇺🇸

Ashland, Kentucky, United States

Iowa Oncology Research Association

🇺🇸

Des Moines, Iowa, United States

Siouxland Hematology-Oncology Associates

🇺🇸

Sioux City, Iowa, United States

University of Kentucky Medical Center

🇺🇸

Lexington, Kentucky, United States

Anne Arundel Medical Center

🇺🇸

Annapolis, Maryland, United States

Louisville VA Medical Center

🇺🇸

Louisville, Kentucky, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Bixby Oncology Center

🇺🇸

Adrian, Michigan, United States

Berkshire Hematology Oncology/Bershire Medical Center

🇺🇸

Pittsfield, Massachusetts, United States

Grand Rapids Clinical Oncology Program CCOP

🇺🇸

Grand Rapids, Michigan, United States

St. Joseph Mercy Oakland

🇺🇸

Pontiac, Michigan, United States

Monroe Clinic

🇺🇸

Monroe, Michigan, United States

St. John's Regional Medical Center

🇺🇸

Joplin, Missouri, United States

Munson Medical Center

🇺🇸

Traverse City, Michigan, United States

Montana Cancer Consortium CCOP

🇺🇸

Billings, Montana, United States

St. John's Health System

🇺🇸

Springfield, Missouri, United States

Cancer Research for the Ozarks

🇺🇸

Springfield, Missouri, United States

Cancer Resource Center

🇺🇸

Lincoln, Nebraska, United States

Good Samaritan Health Systems - Cancer Center

🇺🇸

Kearney, Nebraska, United States

Alegent Health Bergan Mercy Medical Center

🇺🇸

Omaha, Nebraska, United States

Alegent Health Immanuel Medical Center

🇺🇸

Omaha, Nebraska, United States

Washoe Medical Center

🇺🇸

Reno, Nevada, United States

Missouri Valley Cancer Cons CCOP/Creighton University

🇺🇸

Omaha, Nebraska, United States

VAMC New Jersey Health Care System

🇺🇸

East Orange, New Jersey, United States

Warren Hospital

🇺🇸

Phillipsburg, New Jersey, United States

Bassett Research Institute

🇺🇸

Cooperstown, New York, United States

Riverview Medical Center

🇺🇸

Red Bank, New Jersey, United States

Stratton Veterans Affairs Medical Center

🇺🇸

Albany, New York, United States

Glens Falls Hospital

🇺🇸

Glens Falls, New York, United States

Toledo Hospital

🇺🇸

Toledo, Ohio, United States

St. Vincent Medical Center

🇺🇸

Toledo, Ohio, United States

Fremont Memorial Hospital

🇺🇸

Fremont, Ohio, United States

St. Charles Hospital

🇺🇸

Oregon, Ohio, United States

Flower Hospital

🇺🇸

Sylvania, Ohio, United States

Toledo Clinic Inc.

🇺🇸

Toledo, Ohio, United States

Toledo CCOP

🇺🇸

Toledo, Ohio, United States

Muskogee Regional Medical Center

🇺🇸

Muskogee, Oklahoma, United States

St. Luke's Hospital and Health Network

🇺🇸

Bethlehem, Pennsylvania, United States

Lehigh Valley Hospital

🇺🇸

Allentown, Pennsylvania, United States

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

Doylestown Hospital

🇺🇸

Doylestown, Pennsylvania, United States

York Cancer Center/Wellspan Health

🇺🇸

York, Pennsylvania, United States

Thompson Cancer Survival Center

🇺🇸

Knoxville, Tennessee, United States

Baptist Memorial Hospital - Memphis

🇺🇸

Memphis, Tennessee, United States

Sioux Community Cancer Consortium

🇺🇸

Sioux Falls, South Dakota, United States

Methodist Hospitals of Dallas

🇺🇸

Dallas, Texas, United States

Cascadia Clinical Trials at St. Joseph Hospital

🇺🇸

Bellingham, Washington, United States

Scott & White CCOP

🇺🇸

Temple, Texas, United States

Sinai Samaritan Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

Ottawa General Hospital

🇨🇦

Ottawa, Ontario, Canada

San Juan Dr. I. Gonzalez Martinez/Centro Medico

🇵🇷

San Juan, Puerto Rico

Altamira Family Medicine

🇵🇷

San Juan, Puerto Rico

Centro Clinico San Patricio

🇵🇷

San Juan, Puerto Rico

Methodist Regional Cancer Center

🇺🇸

Oak Ridge, Tennessee, United States

Miguel Sosa Padilla, MD/San Juan City Hospital

🇵🇷

San Juan, Puerto Rico

Benefis Health Care

🇺🇸

Great Falls, Montana, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

Meharry Medical College

🇺🇸

Nashville, Tennessee, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath